Home Cart Sign in  
Chemical Structure| 2612-28-4 Chemical Structure| 2612-28-4

Structure of 2612-28-4

Chemical Structure| 2612-28-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 2612-28-4 ]

CAS No. :2612-28-4
Formula : C6H14O2
M.W : 118.17
SMILES Code : OCC(CCC)CO
MDL No. :MFCD00799394
InChI Key :FZHZPYGRGQZBCV-UHFFFAOYSA-N
Pubchem ID :7021156

Safety of [ 2612-28-4 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 2612-28-4 ] Show Less

Physicochemical Properties

Num. heavy atoms 8
Num. arom. heavy atoms 0
Fraction Csp3 1.0
Num. rotatable bonds 4
Num. H-bond acceptors 2.0
Num. H-bond donors 2.0
Molar Refractivity 33.28
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

40.46 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.73
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.55
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.39
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.61
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.61
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.78

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.66
Solubility 26.1 mg/ml ; 0.221 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.97
Solubility 12.6 mg/ml ; 0.107 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.73
Solubility 21.9 mg/ml ; 0.185 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.63 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.16

Application In Synthesis of [ 2612-28-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 2612-28-4 ]

[ 2612-28-4 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 50-00-0 ]
  • [ 142-96-1 ]
  • [ 7426-71-3 ]
  • [ 2612-28-4 ]
  • 2
  • [ 2612-28-4 ]
  • [ 1781-52-8 ]
YieldReaction ConditionsOperation in experiment
84% With sulfuric acid; hydrogen bromide; sodium carbonate; REFERENCE EXAMPLE 1 2-n-Propyl-1,3-dibromopropane To a solution of <strong>[2612-28-4]2-n-propylpropane-1,3-diol</strong> (60.0 g., 0.508 mol) in a mixture of 47% hydrobromic acid (211 g., 1.22 mol) and sulphuric acid (63.5 g., 0.65 mol) was added sulphuric acid (103 g., 1.04 mol). The reaction mixture was refluxed for 16 hours and then subjected to steam distillation. The water-insoluble layer of distillates was separated, washed with water (15 ml.) and an aqueous solution of sodium carbonate (15 ml.), dried over calcium chloride and then distilled (20 mm.Hg., 105 C.-110 C.) to give 104 g. of the title compound (84% yield) having the following physical characteristics: b.p.: 105 C.-110 C. (20 mm.Hg); NMR (CCl4): delta; 3.67-3.30 (4H, multiplet), 2.10-1.80 (1H, multiplet), 1.60-1.18 (4H, multiplet), 1.10-0.84 ppm (3H, multiplet); IR (liquid film): nu; 1460, 1255, 1240, 1210 cm-1; Mass spectrum: m/e=246 (M+ +4), 244 (M+ +2), 242 (M+), 163, 83.
  • 3
  • [ 2163-48-6 ]
  • [ 2612-28-4 ]
YieldReaction ConditionsOperation in experiment
60% With diisobutylaluminium hydride; In dichloromethane; at -78 - 0℃; for 0.5h; Example E; Compound 5 ; {2-Methyl-4-[2-(4-trifluoromethyl-phenoxymethyl)-pentylsulfanyl]-phenoxy}-acetic acid; To a solution of 1.0 M diisobutylaluminum hydride (50 mL, 50 mmol) in CH2CI2 at-78C was added diethyl propylmalonate E1 (2.02 g, 10.0 mmol). The reaction mixture was allowed to gradually warm to 0C, stirred at 0C for 30 min, and quenched with MeOH. The precipitated solid was filtered through Celite and washed with MeOH/CH2CI2. The filtrate was concentrated and purified by column chromatography (EtOAc) to give 709 mg (60%) of E2; 1 H NMR (300 MHz, CDC . s) 8 3. 80 (dd, J = 10.7, 3.8 Hz, 2 H), 3.63 (dd, J = 10.7, 7.7 Hz, 2 H), 2.82 (s, 2 H), 1.84-1. 71 (m, 1 H), 1.42- 1.28 (m, 2 H), 1.24-1. 17 (m, 2 H), 0.91 (t, J = 7. 2 Hz, 3 H) ; MS (ES) m/z : 141 (M+Na+).
  • 4
  • [ 2612-28-4 ]
  • [ 151-50-8 ]
  • [ 4165-98-4 ]
  • 5
  • [ 2612-28-4 ]
  • [ 124-63-0 ]
  • [ 69769-96-6 ]
YieldReaction ConditionsOperation in experiment
94% With triethylamine; In dichloromethane; at 0℃; for 2h; To a solution of E2 (300 mg, 2. 54 mmol) in CH2CI2 (5 mL) at 0C were added Et3N (1.06 mL, 7.62 mmol) and methanesulfonyl chloride (729 mg, 6.36 mmol). The mixture was stirred at 0C for 2 h and diluted with saturated NaHCO3. The organic layer was separated and the aqueous layer was extracted with CH2CI2 (x 3). The combined organic phases were dried, concentrated, and column chromatographed (EtOAc/hexane : 1/1) to provide 655 mg (94%) of E3; 1 H NMR (300 MHz, CDCl3) 8 4.29 (dd, J = 10. 0,4. 3 Hz, 2 H), 4.20 (dd, J = 10. 0,6. 4 Hz, 2 H), 3.05 (s, 6 H), 2.22- 2.15 (m, 1 H), 1.42 (m, 4 H), 0.97-0. 93 (m, 3 H); MS (ES) m/z: 297 (M+Na+).
  • 7
  • [ 2612-28-4 ]
  • [ 2411-58-7 ]
  • [ 141883-07-0 ]
  • 8
  • [ 2612-28-4 ]
  • [ 39633-51-7 ]
  • [ 141883-08-1 ]
  • 9
  • [ 2612-28-4 ]
  • [ 112-96-9 ]
  • [ 141883-09-2 ]
  • 10
  • [ 2612-28-4 ]
  • [ 1200-14-2 ]
  • [ 74800-47-8 ]
  • [ 81220-90-8 ]
  • 11
  • [ 2612-28-4 ]
  • [ 103057-51-8 ]
  • [ 111241-41-9 ]
  • 12
  • [ 2612-28-4 ]
  • [ 41917-85-5 ]
  • [ 95759-40-3 ]
  • 13
  • [ 2612-28-4 ]
  • [ 115809-72-8 ]
  • [ 141883-10-5 ]
  • 14
  • [ 2612-28-4 ]
  • [ 79285-01-1 ]
  • 4-Butyl-cyclohexanecarboxylic acid 4-(5-propyl-[1,3]dioxan-2-yl)-phenyl ester [ No CAS ]
  • 16
  • [ 2612-28-4 ]
  • [ 112-82-3 ]
  • [ 101853-62-7 ]
  • 17
  • [ 2612-28-4 ]
  • [ 32085-88-4 ]
  • 2-(3,5-Difluoro-phenyl)-5-propyl-[1,3]dioxane [ No CAS ]
  • 18
  • [ 824-72-6 ]
  • [ 2612-28-4 ]
  • 2-Phenyl-5-propyl-[1,3,2]dioxaphosphinane 2-oxide [ No CAS ]
  • 2-Phenyl-5-propyl-[1,3,2]dioxaphosphinane 2-oxide [ No CAS ]
  • 19
  • 2-isopropoxy-4-propyl-[1,2]oxaborolane [ No CAS ]
  • [ 2612-28-4 ]
  • 20
  • [ 64-17-5 ]
  • [ 2163-48-6 ]
  • copper-chromium oxide [ No CAS ]
  • [ 2612-28-4 ]
  • 21
  • [ 64-17-5 ]
  • [ 2163-48-6 ]
  • sodium [ No CAS ]
  • [ 58175-57-8 ]
  • [ 71-41-0 ]
  • [ 2612-28-4 ]
  • [ 109-52-4 ]
  • 23
  • 4-(trans-4-formylcyclohexyl)-3-fluorobenzyl methyl ether [ No CAS ]
  • [ 2612-28-4 ]
  • 4-[trans-4-(trans-5-propyl-1,3-dioxan-2-yl)cyclohexyl]-2-fluorobenzyl methyl ether [ No CAS ]
YieldReaction ConditionsOperation in experiment
With p-toluenesulfonic acid monohydrate; In benzene; EXAMPLE 2 A solution of 2 g of 4-(trans-4-formylcyclohexyl)-3-fluorobenzyl methyl ether (produced analogously to Example 1 (a)-k)) and 1.05 g of <strong>[2612-28-4]2-propyl-1,3-propanediol</strong> in 30 ml of benzene is heated to slight boiling with 35 mg of p-toluenesulfonic acid monohydrate. After neutralization of the solution with a few drops of triethylamine the mixture is washed with water, dried over sodium sulphate, filtered and the filtrate is evaporated. Chromatography of the residue on silica gel with methylene chloride and subsequent crystallization from hexane gives 4-[trans-4-(trans-5-propyl-1,3-dioxan-2-yl)cyclohexyl]-2-fluorobenzyl methyl ether.
  • 24
  • [ 2612-28-4 ]
  • [ 2746-25-0 ]
  • [ 443284-32-0 ]
  • 25
  • [ 2612-28-4 ]
  • (2S,5R)-2-(4-Bromo-phenyl)-5-propyl-tetrahydro-pyran [ No CAS ]
  • 26
  • [ 2612-28-4 ]
  • (2S,5S)-2-(4-Bromo-phenyl)-5-propyl-tetrahydro-pyran [ No CAS ]
  • 27
  • [ 2612-28-4 ]
  • [ 911142-61-5 ]
  • 28
  • [ 2612-28-4 ]
  • [ 10317-18-7 ]
  • 29
  • [ 2612-28-4 ]
  • (Z)-(S)-2-Propyl-non-3-enal [ No CAS ]
  • 30
  • [ 2612-28-4 ]
  • (Z)-(S)-2-Propyl-non-3-en-1-ol [ No CAS ]
  • 31
  • [ 2612-28-4 ]
  • (R)-2-(4-Methoxy-benzyloxymethyl)-pentanal [ No CAS ]
  • 32
  • [ 2612-28-4 ]
  • [ 443284-56-8 ]
  • 33
  • [ 2612-28-4 ]
  • (3Z,6Z)-(S)-5-Propyl-dodeca-3,6-dien-1-ol [ No CAS ]
  • 34
  • [ 2612-28-4 ]
  • 1-Methoxy-4-((Z)-(S)-2-propyl-non-3-enyloxymethyl)-benzene [ No CAS ]
  • 35
  • [ 2612-28-4 ]
  • 1-Methoxy-4-((3Z,6Z)-(S)-5-propyl-dodeca-3,6-dienyloxymethyl)-benzene [ No CAS ]
 

Historical Records

Technical Information

Categories